Olio Labs Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $4.5M

  • Investors
  • 8

Olio Labs General Information

Description

Developer of combination therapeutics designed to be effective and have fewer side effects. The company specializes in using artificial intelligence to develop therapeutics that consider various interacting proteins in the body rather than just targeting one or two, enabling patients to be cured effectively.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 434 North Canal Street
  • Suite 7, South
  • San Francisco, CA 94080
  • United States
Primary Industry
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 434 North Canal Street
  • Suite 7, South
  • San Francisco, CA 94080
  • United States

Olio Labs Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Olio Labs Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 19-Mar-2025 $4.5M Completed Startup
1. Seed Round 01-Jul-2023 Completed Startup
To view Olio Labs’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Olio Labs Patents

Olio Labs Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026206942-A1 Combination of glp-1 receptor agonist, mc4r agonist, and hcar2 agonist for use in weight loss Pending 24-Mar-2025
WO-2026183357-A1 Methods of mitigating side effects of nausea and vomiting in female subjects taking glp-1 receptor agonists for weight loss Pending 26-Feb-2025

Olio Labs Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Olio Labs Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Boom Capital Ventures Venture Capital Minority
Olive Capital Angel Group Minority
Overwater Ventures Venture Capital Minority
Pioneer Fund Venture Capital Minority
SciFounders Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Olio Labs FAQs

  • When was Olio Labs founded?

    Olio Labs was founded in 2023.

  • Where is Olio Labs headquartered?

    Olio Labs is headquartered in San Francisco, CA.

  • What is the size of Olio Labs?

    Olio Labs has 10 total employees.

  • What industry is Olio Labs in?

    Olio Labs’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Olio Labs a private or public company?

    Olio Labs is a Private company.

  • What is Olio Labs’s current revenue?

    The current revenue for Olio Labs is .

  • How much funding has Olio Labs raised over time?

    Olio Labs has raised $4.5M.

  • Who are Olio Labs’s investors?

    Boom Capital Ventures, Olive Capital, Overwater Ventures, Pioneer Fund, and SciFounders are 5 of 8 investors who have invested in Olio Labs.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process